Modular Medical’s (NASDAQ: MODD) latest regulatory milestone upgrades the narrative: the company has now secured FDA 510(k) clearance for its Pivot tubeless insulin patch pump, moving from “launch‑ready” to “launch‑approved” in the heart of the fast‑growing diabesity market.
Pivot Patch Pump Gets…
Modular Medical’s (NASDAQ: MODD) latest capital raise seems to read less like a distress flare and more like a carefully aimed flare gun over the diabetes device market, signaling that the small-cap insurgent still plans to play big-league offense in insulin delivery…
Insulet’s (PODD) latest numbers read like the balance sheet of a very determined racehorse: fast, disciplined, and still eager for the next lap, even as a promising upstart named Modular Medical trots onto the same track.
Insulet’s Earnings: Hitting a Full Gallop…
Modular Medical’s (NASDAQ: MODD) Pivot insulin delivery system is quietly building a credible bull case that now extends beyond regulatory momentum and leadership credentials into hard operational execution. With the company achieving a key manufacturing milestone for its Pivot tubeless insulin patch…
